Nivolumab and ipilimumab versus ipilimumab in untreated melanoma

Michael A. Postow, Jason Chesney, Anna C. Pavlick, Caroline Robert, Kenneth Grossmann, David McDermott, Gerald P. Linette, Nicolas Meyer, Jeffrey K. Giguere, Sanjiv S. Agarwala, Montaser Shaheen, Marc S. Ernstoff, David Minor, April K. Salama, Matthew Taylor, Patrick A. Ott, Linda M. Rollin, Christine Horak, Paul Gagnier, Jedd D. WolchokF. Stephen Hodi

    Research output: Contribution to journalArticle

    1660 Scopus citations

    Fingerprint Dive into the research topics of 'Nivolumab and ipilimumab versus ipilimumab in untreated melanoma'. Together they form a unique fingerprint.

    Medicine & Life Sciences